🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌟 Join us today at 7 PM for the 'ISG Meets Patients' webinar! Expert physicians will answer patient questions on innovative topics related to diagnosis and treatment of #sarcomas. Don't miss out!! See you there! #sarcoma #patients #SarcomaAwarenessMonth italiansarcomagroup.org/isg-incontra-i…

Crizotinib now available for adult Italian ALK + IMT patients under law 648/96! Thrilled to share this with our community! Thanks to all clinicians and patients who made this possible! 👉tinyurl.com/7zjbecw4 🎗️ #Sarcoma #SarcomaAwarenessMonth

Great sadness to hear that the British pathologist Professor Christopher Fletcher has passed away. Permanent gratitude for his milestone contribution, a precious legacy for all. Our condolences to Professor Fletcher's family, friends and colleagues.

Retrospective study by Ultra-Rare Sarcoma Working Group on metastatic low-grade fibromyxoid sarcoma(LGFMS), sclerosing epithelioid fibrosarcoma(SEF), and hybrid(H)-LGFMS/SEF across 28 global centres ESMO Open ESMO - Eur. Oncology Small N but provocative PFS curves sciencedirect.com/science/articl…

"Exciting insights from Prof. Gounder delivering an inspiring lecture at the ISG Journal Club: How can we advance with MDM2 inhibition in LPS? Italian Sarcoma Group CTOS Alessandro Gronchi Roberta Sanfilippo Silvia Stacchiotti

Semiannual meeting of the EORTC Soft Tissue and #Sarcoma Group happening now in a wonderful venue at University of Turin Silvia Stacchiotti Paul Huang Lab Lorenzo D'Ambrosio Alessandra Merlini @winanvanhoudt leading this important scientific day CTOS Istituto Tumori Italian Sarcoma Group TARPSWG

The semiannual meeting of the EORTC Soft Tissue and Bone #Sarcoma Group has come to a close. It was wonderful to meet colleagues and friends from across Europe, all united in advancing academic research for our sarcoma patients. If you want to go far, go together!

Great EORTC Soft Tissue and Bone Sarcoma Group Meeting in Turin! Thanks to all the attendees for the fruitful discussion!! Looking forward to future steps @winanvanhoudt Silvia Stacchiotti Alessandro Gronchi Alessandra Merlini Sarcoma UniTo Italian Sarcoma Group Paul Huang Lab de Miranda Lab EORTC

Join us for the TARPSWG semiannual meeting at #CTOS2024 in beautiful #SanDiego , where we’re diving into the latest in #retroperitoneal #sarcoma research and treatment! Looking forward to discussions and updates! Alessandro Gronchi @SoMe4sarcoma Jason Sicklick CTOS

Happiest aspect of attending #inperson #CTOS2024 is to meet all the wonderful friends and collaborators in the 🌍 #sarcoma community. This really helps drive continual motivaton to advance our field forward together for our patients. CTOS Emanuela Palmerini Aga Wozniak

Milan Istituto Tumori crew at #CTOS2024 Chirurgia dei Sarcomi INT 😀

📣Giovedì 30 gennaio alle ore 13.30 su #Rai2 , nella rubrica del Tg2🟥"Tutto il bello che c'è" andrà in onda un servizio sull'Italian Sarcoma Group ISG. 🎗️ Per vederlo in diretta streaming ➡️ raiplay.it/dirette/rai2 #30gennaio #ItalianSarcomaGroup

FDA Approves Vimseltinib for Symptomatic Tenosynovial Giant Cell Tumor. Vimseltinib achieved a 40% ORR in #TGCT patients, significantly outperforming placebo in the MOTION trial. ⁦TGCT Support⁩ ⁦The Life Raft Group⁩ #sarcoma onclive.com/view/fda-appro…

#ISG2025 opened with a thought-provoking session on the role of artificial intelligence in risk prediction nomograms. #AI is an exciting tool on the horizon, but it still doesn't outperform Cox models for accurate risk prediction in #sarcoma. #Artificialintellgence Dario Callegaro

Deep dive into conventional and dedifferentiated #chondrosarcoma. From evolving pathology, to imaging, molecular targets, medical and radiation therapy — a full-spectrum update on a complex disease. #SarcomaResearch #ISG2025 #Oncology

🧬 Genetic Predisposition in Sarcoma Up to 20% #sarcoma may be assoc. with predisposition genes In our 📝 we review evidence on genetic predis. & how it may influence Rx decisions & management inc. surgery, radiotherapy, systemic Rx & surveillance 1/4 thelancet.com/journals/eclin…

Check it out ⬇️⬇️⬇️⬇️

EP300::VGLL3 #rhabdomyosarcoma: a potential distinct indolent adult RMS subtype 🚨Think of this emerging subtype if: ✔️Male, aged 30-60 ✔️ Spindle cell / sclerosing #RMS 👅 of the tongue 🙌🏻 Appear indolent with good outcomes in all reported cases esmorarecancers.org/article/S3050-

So proud, for my first #ASCO25, to present work on pediatric #TGCT on behalf of TGCT Support ☺️ grateful for the opportunity to raise awareness

#ASCO25, pimicotinib led to significant ORR via RECIST 1.1 was 54% at Week 25, exciting potential option for patients with #TGCT